Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia flag Australia · Delayed Price · Currency is AUD
10.37
+0.18 (1.77%)
Jun 27, 2025, 4:10 PM AEST

Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of 518.60 million as of June 27, 2025. Its market cap has decreased by -29.08% in one year.

Market Cap
518.60M
Enterprise Value
321.10M
Revenue
91.02M
Ranking
n/a
PE Ratio
13.48
Stock Price
10.37

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 518.60M, an increase of 9,824.12%. That is a compound annual growth rate of 20.75%.

History

DateMarket Cap% Change
Jun 27, 2025518.60M-13.90%
Dec 31, 2024602.36M-24.90%
Dec 29, 2023802.04M-25.09%
Dec 30, 20221.07B-20.36%
Dec 31, 20211.34B21.91%
Dec 31, 20201.10B-21.55%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 115.46B
Pro Medicus 29.01B
Cochlear 19.43B
Sonic Healthcare 12.66B
Ramsay Health Care 8.23B
Telix Pharmaceuticals 8.23B
Ansell 4.39B
Regis Healthcare 2.29B
Market Cap Rankings